Literature DB >> 34818481

New Horizons in the Treatment of Osteosarcoma.

Paul S Meltzer1, Lee J Helman1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34818481     DOI: 10.1056/NEJMra2103423

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.

Authors:  Lawrence M White; Angela Atinga; Ali M Naraghi; Katherine Lajkosz; Jay S Wunder; Peter Ferguson; Kim Tsoi; Anthony Griffin; Masoom Haider
Journal:  Skeletal Radiol       Date:  2022-07-01       Impact factor: 2.199

2.  Characteristics and significance of T lymphocyte subsets in peripheral blood of osteosarcoma mice.

Authors:  Qi Liu; Rui Xu; Xuan Xu; Yulin Huang; Zhengliang Ma
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

Review 3.  Surgical Treatment of Bone Sarcoma.

Authors:  Felix Bläsius; Heide Delbrück; Frank Hildebrand; Ulf Krister Hofmann
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

Review 4.  Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives.

Authors:  Joaquim Soares do Brito; Miguel Esperança-Martins; André Abrunhosa-Branquinho; Cecilia Melo-Alvim; Raquel Lopes-Brás; João Janeiro; Dolores Lopez-Presa; Isabel Fernandes; José Portela; Luis Costa
Journal:  Cancers (Basel)       Date:  2022-05-22       Impact factor: 6.575

5.  Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs.

Authors:  Guowei Wang; Xiaobo Zhang; Wanjiang Feng; Jianlong Wang
Journal:  Front Genet       Date:  2022-05-26       Impact factor: 4.772

6.  A Web-Based Prediction Model for Overall Survival of Elderly Patients With Malignant Bone Tumors: A Population-Based Study.

Authors:  Jie Tang; JinKui Wang; Xiudan Pan
Journal:  Front Public Health       Date:  2022-01-11

7.  Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma.

Authors:  Di Zheng; Zhun Wei; Weichun Guo
Journal:  Front Genet       Date:  2022-04-19       Impact factor: 4.772

8.  Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression.

Authors:  Yubo Shi; Yunyun Tian; Xiangran Sun; Yonglong Qiu; Yingchun Zhao
Journal:  Front Oncol       Date:  2022-04-13       Impact factor: 5.738

9.  Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling.

Authors:  Lingfeng Yu; Hao Zhu; Zhen Wang; Jianhao Huang; Yan Zhu; Gentao Fan; Yicun Wang; Xi Chen; Guangxin Zhou
Journal:  Mol Cancer       Date:  2022-08-19       Impact factor: 41.444

10.  CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway.

Authors:  Jun Cheng; Yan Zhang; Rongjun Wan; Jun Zhou; Xin Wu; Qizhi Fan; Jingpeng He; Wei Tan; Youwen Deng
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.